While all patients with atrial fibrillation should receive anticoagulation and control of ventricular response, it is not clear whether conversion to sinus rhythm is associated with a good long-term outcome. Data are presented detailing current physician practices regarding conversion to sinus rhythm (preferred by 90%) and why participation in the new National Institute of Health trial of atrial fibrillation is desirable.